Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice

31Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background and purpose: Hepatic encephalopathy is a neuropsychiatric syndrome caused by liver failure. In view of the effects of cannabinoids in a thioacetamide-induced model of hepatic encephalopathy and liver disease and the beneficial effect of capsaicin (a TRPV1 agonist) in liver disease, we assumed that capsaicin may also affect hepatic encephalopathy. Experimental approach: Fulminant hepatic failure was induced in mice by thioacetamide and 24 h later, the animals were injected with one of the following compound(s): 2-arachidonoylglycerol (CB 1, CB 2 and TRPV1 receptor agonist); HU308 (CB 2 receptor agonist), SR141716A (CB 1 receptor antagonist); SR141716A+2-arachidonoylglycerol; SR144528 (CB 2 receptor antagonist); capsaicin; and capsazepine (TRPV1 receptor agonist and antagonist respectively). Their neurological effects were evaluated on the basis of activity in the open field, cognitive function in an eight-arm maze and a neurological severity score. The mice were killed 3 or 14 days after thioacetamide administration. 2-arachidonoylglycerol and 5-hydroxytryptamine (5-HT) levels were determined by gas chromatography-mass spectrometry and high-performance liquid chromatography with electrochemical detection, respectively. Results: Capsaicin had a neuroprotective effect in this animal model as shown by the neurological score, activity and cognitive function. The effect of capsaicin was blocked by capsazepine. Thioacetamide induced astrogliosis in the hippocampus and the cerebellum and raised brain 5-hydroxytryptamine levels, which were decreased by capsaicin, SR141716A and HU-308. Thioacetamide lowered brain 2-arachidonoylglycerol levels, an effect reversed by capsaicin. Conclusions: Capsaicin improved both liver and brain dysfunction caused by thioacetamide, suggesting that both the endocannabinoid and the vanilloid systems play important roles in hepatic encephalopathy. Modulation of these systems may have therapeutic value. © 2009 The British Pharmacological Society.

Cited by Powered by Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Avraham, Y., Grigoriadis, N. C., Magen, I., Poutahidis, T., Vorobiav, L., Zolotarev, O., … Berry, E. M. (2009). Capsaicin affects brain function in a model of hepatic encephalopathy associated with fulminant hepatic failure in mice. British Journal of Pharmacology, 158(3), 896–906. https://doi.org/10.1111/j.1476-5381.2009.00368.x

Readers over time

‘10‘13‘14‘15‘16‘17‘18‘19‘20‘21‘22‘23‘2402468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

60%

Professor / Associate Prof. 4

20%

Researcher 4

20%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 4

29%

Medicine and Dentistry 4

29%

Pharmacology, Toxicology and Pharmaceut... 3

21%

Neuroscience 3

21%

Save time finding and organizing research with Mendeley

Sign up for free
0